Avaliação do custo do medicamento para tratamento ambulatorial de pacientes com dor crônica
Evaluating the cost of drugs used in the outpatient treatment of chronic pain
Roberto Vlainich; Paola Zucchi; Adriana Machado Issy; Rioko Kimiko Sakata
Resumo
Palavras-chave
Abstract
Keywords
Referências
Melo DO, Ribeiro E, Storpirtis S. A importância e a história dos estudos de utilização de medicamentos. RBCF Rev Bras Cienc Farm. 2006;42:475-485.
Lessard C, Contandriopoulos AP, Beaulieu MD. The role of economic evaluation in the decision-making process of family physicians: design and methods of a qualitative embedded multiple-case study. BMC Farm Pract. 2009;10.
Robertson J, Lang D, Hill S. Use of pharmacoeconomics in prescribing research: Part 1: costs-moving beyond the acquisition price for drugs. J Clin Pharm Ther. 2003;28:73-79.
Zanini AC, Farhat FCLG, Ribeiro E. Farmacoeconomia: conceitos e aspectos operacionais. RBCF Rev Bras Cienc Farm. 2001;37:225-237.
Guillemin F, Bombardier C, Beaton D. Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol. 1993;46:1417-1432.
Fitzpatrick R, Fletcher A, Gore S. Quality of life measures in health care: I: Applications and issues in assessment. BMJ. 1992;305:1074-1077.
The World Health Organization Quality of Life Assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med. 1995;41:1403-1409.
Shlipak MG. Análise de Decisão. Friedland Medicina Baseada em Evidências: uma Estrutura para a Prática Clínica. 2001:32-51.
Cramer JA, Spilker B. Quality of Life and Pharmacoeconomics. 1998:221-264.
Rittenhouse BE. Designing and Conducting Cost-Minimization and Cost-Effectiveness Analyses. Quality of Life and Pharmacoeconomics in Clinical Trials. 1996:741-745.
Davies L, Cossins L, Bowsher D. The cost of treatment for postherpetic neuralgia in the UK. Pharmacoeconomics. 1994;6:142-148.
Manktelow RT, Binhammer P, Tomat LR. Carpal tunnel syndrome: cross-sectional and outcome study in Ontario workers. J Hand Surg(Am). 2004;29:307-317.
Scott FT, Johnson RW, Leedham-Green M. The burden of herpes zoster: a prospective population based study. Vaccine. 2006;24:1308-1314.
Cepeda MS, Farrar JT. Economic evaluation of oral treatments for neuropathic pain. J Pain. 2006;7:119-128.
O'Connor AB. Re: sequential medication strategies for postherpetic neuralgia: a cost-effectiveness analysis. J Pain. 2007;8:674-676.
Rodríguez MJ, Díaz S, Vera-Llonch M. Cost-effectiveness analysis of pregabalin versus gabapentin in the management of neuropathic pain due to diabetic polyneuropathy or post-herpetic neuralgia. Curr Med Res Opin. 2007;23:2585-2596.
Smith KJ, Roberts MS. Sequential medication strategies for postherpetic neuralgia: a cost-effectiveness analysis. J Pain. 2007;8:396-404.
Beard SM, McCrink L, Le TK. Cost effectiveness of duloxetine in the treatment of diabetic peripheral neuropathic pain in the UK. Curr Med Res Opin. 2008;24:385-399.
Facebook
Google+
Twitter
LinkedIn
Mendeley
StumbleUpon
CiteULike
Reddit
Email